Back

Plasma of COVID-19 positive patients promote oxidative stress and proinflammatory responses in endothelial cells: Potential role of the pro-inflammatory cytokines/SGLT2 pathway.

28 August 2022 (09:15 - 09:30)
Organised by:
Congress Presentation Part of: Basic and Translational Late-Breaking Science 1 Drugs, Drug Targets ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Ali Mroueh

Strasbourg (France)

3 More presentations in this session

Presentation thumbnail
Intravascular administration of soluble Sars-CoV-2 Spike protein triggers non-infective heart and lung inflammation and vascular pericytes rarefaction in healthy mice.
Doctor E. Avolio (Bristol, GB)
Slides Video
Presentation thumbnail
CRISPR/Cas9 editing of CaMKII as a strategy for cardioprotection against ischemia/reperfusion injury.
Professor S. Lebek (Regensburg, DE)
Slides Video
Presentation thumbnail
Is empagliflozin still cardioprotective in SGLT2 KO mice?
Miss S. Chen (Amsterdam, NL)
Slides Video

Access the full session

Session thumbnail
Basic and Translational Late-Breaking Science 1
Video

The Event

Event poster

ESC Congress 2022

28 August 2022 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Takotsubo patient plasma induce endothelial eNOS-NO/ROS imbalance promoting monocyte and platelet adhesion: Protective effects of beta2-adrenergic receptor stimulation and SGLT2 inhibition
thumbnail
Congress Presentation
SGLT2 expression in the left ventricle of cardiac patients is correlated with low-grade inflammation involving the pro-oxidant AT1R/NADPH oxidases/SGLT2 crosstalk: potential role in heart failure
thumbnail
Congress Presentation
Human epicardial adipose tissue-derived factors promote atrial endothelial dysfunction: role of pro-inflammatory cytokines and AT1R/NADPH oxidases/SGLT2 pro-oxidant pathway

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources